Expertise at Chang Gung System

Huang, Hsuan-Ying ,M.D.
Intitution: Kaohsiung Chang Gung Memorial Hospital/ Chang Gung University
Position: Director/Professor
Department: Anatomical Pathology
Address: 123 Ta-Pei Road, Niao-Sung, Kaohsiung, Taiwan
Tel: +886-7-7317123#2537 Fax: +886-7-7333198
E-mail: hyhuang@cgmh.org.tw

Focus of Interest:
  • Oncology
  • Orthopedics
  • Pathology
  • Surgery

Fulltime Employment:
  • Jul 2010 ~ present Director of Anatomical Pathology, Kaohsiung Chang Gung Memorial Hospital
  • Jul 2009 ~ Jun 2010 Associate Director of Anatomical Pathology, Kaohsiung Chang Gung Memorial Hospital
  • Jul 2001 ~ Jun 2003 Research fellow of bone and soft tissue tumors Dep't of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
  • Aug 1999 ~ Jun 2009 Staff Pathologist, Dep't of Anatomical Pathology Kaohsiung Chang Gung Memorial Hospital
  • Jul 1995 ~ Jul 1999 Resident, Dep't of Anatomical Pathology Kaohsiung, Chang Gung Memorial Hospital
  • Jan 1995 ~ Jun 1995 Resident, Dep't of Neurology Kaohsiung Medical University Hospital, Kaohsiung City, Taiwan

Education:
  • Sept. 1986 – June 1993 M.D., Kaohsiung Medical University School of Medicine, Kaohsiung, Taiwan

Honors and Awards:
  1. Senior grant proposal reviewers of national council of science – forensic medicine and pathology (2008, 2009, 2011, 2012, 2014)
  2. Senior member of editorial board: International Journal of Clinical and Experimental Pathology (SCI)
  3. Guest editor of Pathology Research International
  4. Educational member of molecular pathology committee of Taiwan Society of Pathology
  5. Consultant and study group convener of bone and soft tissue pathology of Taiwan Society of Pathology
  6. Concilor of Taiwan Society of Pathology
  7. Co-convener of the 7th (Taipei, Taiwan) and 8th (Busan, Korea) Asia-Pacific IAP congress, bone and soft tissue session
  8. Invited external reviewer: Journal: Pathology (SCI), Laryngoscope (SCI), Journal of Cellular Physiology (SCI), TOHOKU J EXP MED (SCI), BMC Cancer (SCI), Clinical Cancer Research (SCI), Cancer Research (SCI), Acta dermatologica Sinica Grant proposal: University College London Hospitals-NHS Foundation Trust
  9. WHO Classification of Tumours, Pathology &Genetics Tumours of Soft tissue and Bone: invited author for myxofibrosarcoma
  10. 2009 Wu Da-You memorial award endowed by Taiwan national council of science
  11. 2010 Yeh Su Foundation best paper award of the year endowed by Taiwan Society of Pathology

 

Selected Main Publications:
  1. Huang HY, Illei PB, Zhao Zq, Mazumdar M, Huvos AG, Healey JH, Wexler LH, Gorlick R, Meyers P, Ladanyi M. Ewing sarcomas with p53 mutation or p16/p14ARF homozygous deletion: a highly lethal subset associated with poor chemoresponse J Clin Oncol 2005, 20;23(3):548-58. (SCI, 2013 IF: 17.879, rank: 5/202=2.5% in Oncology)
  2. Li CF, Huang WW, Wu JM, Yu SC, Hu TH, Uen YH, Tian YF, Lin CN, Lu D, Fang FM, Huang HY*. Heat Shock Protein 90 Overexpression Independently Predicts Inferior Disease-free Survival with Differential Expression of the α and β Isoforms in Gastrointestinal Stromal Tumors. Clinical Cancer Research 2008, Dec 1; 14(23):7822-31. (SCI 2013 IF: 8.193, rank, 13/202=6.4 % in Oncology, corresponding author, NSC 95-2320-B-182A-007 -MY2, 98年台灣病理學會-葉曙基金會最佳論文)
  3. Huang HY, Li SH, Yu SC, Chou FF, Tzeng CC, Hu TH, Uen YH, Tian YF, Wang YH, Fang FM, Huang WW, Wei YC, Wu JM, Li CF*. Homozygous Deletion of MTAP gene as a Poor Prognosticator in Gastrointestinal Stromal Tumors. Clinical Cancer Research 2009; 15(22): 6963-72. (SCI 2013 IF: 8.193, rank, 13/202=6.4 % in Oncology, NSC 94-2320-B-182A-005, NSC 95-2320-B-182A-007 -MY2, CMRPG850442, 99年台灣病理學會-葉曙基金會最佳論文)
  4. Huang HY, Wu WR, Wang YH, Wang JW, Fang FM, Tsai JW, Li SH, Hung HC, Yu SC, Lan J, Shiue YL, Hsing CH, Chen LT, Li CF. ASS1 as a Novel Tumor Suppressor Gene in Myxofibrosarcomas: aberrant loss via epigenetic DNA methylation confers aggressive phenotypes, negative prognostic impact, and therapeutic relevance. Clinical Cancer Research 2013 Jun 1;19(11):2861-2872. (SCI 2013 IF: 8.193, rank, 13/202=6.4 %in Oncology)
  5. Li CF, Fang FM, J Lan, JW Wang, Kung HJ, Chen LT, TJ Chen, Li SH, Wang YW, HC Tai, Yu SC, HY Huang*. AMACR amplification in myxofibrosarcomas: a mechanism of overexpression that promotes cell proliferation with therapeutic relevance. Clinical Cancer Research (SCI in press, 2013 IF: 8.193, rank, 13/202=6.4 % in Oncology)

 

All Publications List

Board Certification:
  1. Diploma of the Board of Pathology in Anatomic Pathology No. 0263